1834 Investment Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-31
Closed -$1K 461
2020
Q3
$1K Hold
31
﹤0.01% 409
2020
Q2
$1K Hold
31
﹤0.01% 436
2020
Q1
$1K Hold
31
﹤0.01% 388
2019
Q4
$1K Hold
31
﹤0.01% 438
2019
Q3
$1K Hold
31
﹤0.01% 443
2019
Q2
$1K Hold
31
﹤0.01% 425
2019
Q1
$1K Hold
31
﹤0.01% 397
2018
Q4
$1K Hold
31
﹤0.01% 394
2018
Q3
$2K Hold
31
﹤0.01% 386
2018
Q2
$2K Hold
31
﹤0.01% 404
2018
Q1
$1K Hold
31
﹤0.01% 434
2017
Q4
$1K Buy
+31
New +$1.43K ﹤0.01% 441

Other funds holding AVNS

1834 Investment Advisors's AVNS Position: Q4 2020 in Review

1834 Investment Advisors sold out of Avanos Medical (AVNS) in Q4 2020, closing a stake of 31 shares — an estimated $1K sold.

1834 Investment Advisors first reported a position in AVNS in Q4 2017 and held it in 12 quarters. The position peaked at $2K in Q3 2018. 281 funds tracked by Wall St. Rank hold AVNS as of Q4 2020.

  • 1834 Investment Advisors reported no remaining Avanos Medical position as of Q4 2020 after selling out during the quarter.
  • 1834 Investment Advisors sold 31 Avanos Medical shares in Q4 2020, an estimated $1K.
  • 1834 Investment Advisors first reported a position in Avanos Medical in Q4 2017 and held it in 12 quarters.
  • 1834 Investment Advisors's Avanos Medical position peaked at $2K in Q3 2018.
  • 281 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2020.

Based on 1834 Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.